Immunization of children with secondary immunodeficiency

References

• Chinen J, Sharer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol 2010; 125:195-203; PMID:20042227 http://dx.doi.org/10.1/t016/j.jaci.2009.08.040
   PubMed Web of Science ®Google Scholar
• Ruggiero A, Battista A, Coccia P, Attinà G, Riccardi R. How to manage vaccinations in children with cancer. Pediatr Blood Cancer 2011; 57:1104-8; PMID:21953691; http://dx.doi.org/10.1002/pbc.23333
   PubMed Web of Science ®Google Scholar
• Esposito S, Cecinati V, Scicchitano B, Delvecchio GC, Santoro N, Amato D, Pelucchi C, Jankovic M, De Mattia D, Principi N. Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine 2010; 28:1558-65; PMID:20003924; http://dx.doi.org/10.1016/j.vaccine.2009.11.055
   PubMed Web of Science ®Google Scholar
• Dhir S, Slatter M, Skinner R. Recent advances in the management of graft-versus-host disease. Arch Dis Child 2014; 99:1150-7; PMID:25016613; http://dx.doi.org/10.1136/archdischild-2013-304832
   PubMed Web of Science ®Google Scholar
• Breda L, Del Torto M, De Sanctis S, Chiarelli F. Biologics in children's autoimmune disorders: efficacy and safety. Eur J Pediatr 2011; 170:157-67; PMID:20556424; http://dx.doi.org/10.1007/s00431-010-1238-z
   PubMed Web of Science ®Google Scholar
• Esposito S, Mastrolia MV, Prada E, Pietrasanta C, Principi N. Vaccine administration in children with chronic kidney disease. Vaccine 2014; 32:6601-6; PMID:25275950; http://dx.doi.org/10.1016/j.vaccine.2014.09.038
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Vaccine use in primary immunodeficiency disorders. Vaccine 2014; 32:3725-31; PMID:24837766; http://dx.doi.org/10.1016/j.vaccine.2014.05.022
   PubMed Web of Science ®Google Scholar
• Moir S, Fauci AS. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 2008; 122:12-9; PMID:18547629; http://dx.doi.org/10.1016/j.jaci.2008.04.034
   PubMed Web of Science ®Google Scholar
• Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994; 95:436-41; PMID:7907956; http://dx.doi.org/10.1111/j.1365-2249.1994.tb07015.x
   PubMed Web of Science ®Google Scholar
• Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 1994; 83:3101-3; PMID:7514053
   PubMed Web of Science ®Google Scholar
• De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, Grutzmeier S, Sönnerborg A, Chiodi F. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-6; PMID:14604962; http://dx.doi.org/10.1182/blood-2003-07-2375
   PubMed Web of Science ®Google Scholar
• Titanji K, De Milito A, Cagigi A, Thorstensson R, Grützmeier S, Atlas A, Hejdeman B, Kroon FP, Lopalco L, Nilsson A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-7; PMID:16645169; http://dx.doi.org/10.1182/blood-2005-11-013383
   PubMed Web of Science ®Google Scholar
• Pensieroso S, Cagigi A, Palma P, Nilsson A, Capponi C, Freda E, Bernardi S, Thorstensson R, Chiodi F, Rossi P. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci USA 2009; 106:7939-44; PMID:19416836; http://dx.doi.org/10.1073/pnas.0901702106
   PubMed Web of Science ®Google Scholar
• Zanchetta M, Anselmi A, Vendrame D, Rampon O, Giaquinto C, Mazza A, Accapezzato D, Barnaba V, De Rossi A. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther 2008; 13:47-55; PMID:18389898
   PubMed Web of Science ®Google Scholar
• Esposito S, Tagliaferri L, Daleno C, Valzano A, Picciolli I, Tel F, Prunotto G, Serra D, Galeone C, Plebani A, et al. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Vaccine 2011; 29:1677-82; PMID:21199699; http://dx.doi.org/10.1016/j.vaccine.2010.12.047
   PubMed Web of Science ®Google Scholar
• Tanzi E, Esposito S, Bojanin J, Amendola A, Trabattoni D, Pariani E, Pinzani R, Zanetti A, Principi N. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy. J Med Virol 2006; 78:440-5; PMID:16482542
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, et al. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J 2006; 25:920-9; PMID:17006288
   PubMed Web of Science ®Google Scholar
• Lujan-Zilbermann J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ, Heckman B, Manzella A, Kabat B, Jean-Philippe P, et al. Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus. J Pediatr 2012; 161:676-81; PMID:22622049
   PubMed Web of Science ®Google Scholar
• Ching N, Deville JG, Nielsen KA, Ank B, Wei LS, Sim MS, Wolinsky SM, Bryson YJ. Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART) Eur J Pediatr 2007; 166:51-6; PMID:16868780
   PubMed Web of Science ®Google Scholar
• Rosenblatt HM, Song LY, Nachman SA, Stanley KE, Krogstad PA, Johnson GM, Wiznia AA; Pediatric Aids Clinical Trials Group 377 Study Team. Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection. J Allergy Clin Immunol 2005; 116:698-703; PMID:16159645
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J; et al. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics 2007; 120: e1190-202; PMID:17938165
   PubMed Web of Science ®Google Scholar
• Mutwa PR, Boer KR, Rusine JB, Muganga N, Tuyishimire D, Reiss P, Lange JM, Geelen SP. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda. Pediatr Infect Dis J 2013; 32:246-51; PMID:22976050
   PubMed Web of Science ®Google Scholar
• Tangsinmankong N, Kamchaisatian W, Day NK, Sleasman JW, Emmanuel PJ. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy. Ann Allergy Asthma Immunol 2004; 92:558-64; PMID:15191025
   PubMed Web of Science ®Google Scholar
• Tarragó D, Casal J, Ruiz-Contreras J, Ramos JT, Rojo P, Snippe H, Jansen WT; Spanish Network Pneumococcus Study Group. Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection. Clin Diagn Lab Immunol 2005; 12:165-70
   PubMedGoogle Scholar
• Viganò A, Zuccotti GV, Pacei M, Erba P, Castelletti E, Giacomet V, Amendola A, Pariani E, Tanzi E, Clerici M. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr 2008; 48:289-96; PMID:18545155
   PubMed Web of Science ®Google Scholar
• Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Vaccine 2012; 30:879-85; PMID:22155630
   PubMed Web of Science ®Google Scholar
• Choudhury SA, Matin F. Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine. Int J Infect Dis 2013; 17: e1249-51; PMID:24139228
   PubMedGoogle Scholar
• Fernandes SJ, Slhessarenko N, Souto FJ. Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine. Vaccine 2008; 26:1032-7; PMID:18242796
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams. Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy. Vaccine 2013; 31:4782-90; PMID:23954381
   PubMed Web of Science ®Google Scholar
• Pensieroso S1, Cagigi A, Palma P, Nilsson A, Capponi C, Freda E, Bernardi S, Thorstensson R, Chiodi F, Rossi P. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci USA 2009; 106:7939-44; PMID:19416836
   PubMed Web of Science ®Google Scholar
• Cagigi A, Rinaldi S, Cotugno N, Manno EC, Santilli V, Mora N, Zangari P, Aquilani A, Tchidjou KH, Giaquinto C, et al. Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up. Pediatr Infect Dis J 2014;33:e126-31; PMID:24378939; http://dx.doi.org/10.1097/INF.0000000000000144
   PubMed Web of Science ®Google Scholar
• Phung BC, Launay O. Vaccination against viral hepatitis of HIV-1 infected patients. Hum Vaccin Immunother 2012;8:554-9; PMID:22634451; http://dx.doi.org/10.4161/hv.19105
   PubMed Web of Science ®Google Scholar
• Valour F, Cotte L, Voirin N, Godinot M, Ader F, Ferry T, Vanhems P, Chidiac C. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine 2014; 32:4558-64; PMID:24951870; http://dx.doi.org/10.1016/j.vaccine.2014.06.015
   PubMed Web of Science ®Google Scholar
• Giacomet V, Penagini F, Trabattoni D, Viganò A, Rainone V, Bernazzani G, Bonardi CM, Clerici M, Bedogni G, Zuccotti GV. Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults. Vaccine 2014; 32:5657-61; PMID:25149430; http://dx.doi.org/10.1016/j.vaccine.2014.08.011
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Qin M, Levin MJ, Fenton T, Beeler JA, Bellini WJ, Audet S, Sowers SB, Borkowsky W, Nachman SA, et al. Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis 2012; 206:512-22; PMID:22693229; http://dx.doi.org/10.1093/infdis/jis386
   PubMed Web of Science ®Google Scholar
• Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin Infect Dis 2007; 45:637-42; PMID:17683001; http://dx.doi.org/10.1086/520651
   PubMed Web of Science ®Google Scholar
• Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B, Pediatric AIDS Clinical Trials Group 265 Team. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis 2006; 194:247-55; PMID:16779732; http://dx.doi.org/10.1086/505149
   PubMed Web of Science ®Google Scholar
• Cagigi A, Cotugno N, Giaquinto C, Nicolosi L, Bernardi S, Rossi P, Douagi I, Palma P. Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions. Hum Vaccin Immunother 2012; 8:1784-94; PMID:22906931; http://dx.doi.org/10.4161/hv.21827
   PubMed Web of Science ®Google Scholar
• Farquhar C, Wamalwa D, Selig S, John-Stewart G, Mabuka J, Majiwa M, Sutton W, Haigwood N, Wariua G, Lohman-Payne B. Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination. Pediatr Infect Dis J 2009; 28:295-9; PMID:19258919; http://dx.doi.org/10.1097/INF.0b013e3181903ed3
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. The present and future of tuberculosis vaccinations. Tuberculosis (Edinb) 2015; 95:6-13; PMID:25458613; http://dx.doi.org/10.1016/j.tube.2014.10.004
   PubMed Web of Science ®Google Scholar
• Menson EN, Mellado MJ, Bamford A, Castelli G, Duiculescu D, Marczyńska M, Navarro M, Scherpbier HJ, Heath PT; Paediatric European Network for Treatment of AIDS (PENTA) Vaccines Group; PENTA Steering Committee; Children's HIV Association (CHIVA). Guidance on vaccination of HIV-infected children in Europe. HIV Med 2012; 13:333–6; e1-14; PMID:22296225; http://dx.doi.org/10.1111/j.1468-1293.2011.00982.x
   PubMedGoogle Scholar
• Esposito S, Cecinati V, Brescia L, Principi N. Vaccinations in children with cancer. Vaccine 2010; 28:3278-84; PMID:20226246; http://dx.doi.org/10.1016/j.vaccine.2010.02.096
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332:143-49; PMID:7800006; http://dx.doi.org/10.1056/NEJM199501193320303
   PubMed Web of Science ®Google Scholar
• Mackall CL. T-cell immunodeficiency following antineoplastic therapy: a review. Stem Cells 2000; 18:10-18; PMID:10661568; http://dx.doi.org/10.1634/stemcells.18-1-10
   PubMed Web of Science ®Google Scholar
• Patel SR, Ortin M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 2007; 44:635-42; PMID:17278052; http://dx.doi.org/10.1086/511636
   PubMed Web of Science ®Google Scholar
• Kosmidis S, Baka M, Bouhoutsou D, Doganis D, Kallergi C, Douladiris N, Pourtsidis A, Varvoutsi M, Saxoni-Papageorgiou F, Vasilatou-Kosmidis H. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL. Pediatr Blood Cancer 2008; 50:528-32; PMID:17853465; http://dx.doi.org/10.1002/pbc.21327
   PubMed Web of Science ®Google Scholar
• Luthy KE, Tiedeman Me, Beckstrand RL, Mills DA. Safety of live-virus vaccines for children with immune deficiency. J Am Acad Nurse Pract 2006; 18:494-503; PMID:16999715; http://dx.doi.org/10.1111/j.1745-7599.2006.00163.x
   PubMed Web of Science ®Google Scholar
• Gangappa S, Kokko KE, Carlson LM, Gourley T, Newell KA, Pearson TC, Ahmed R, Larsen CP. Immune responsiveness and protective immunity after transplantation. Transpl Int 2008; 21:293-303; PMID:18225995; http://dx.doi.org/10.1111/j.1432-2277.2007.00631.x
   PubMed Web of Science ®Google Scholar
• Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J, Small T, Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, European Blood and Marrow Transplant Group, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44:521-6; PMID:19861986; http://dx.doi.org/10.1038/bmt.2009.263
   PubMed Web of Science ®Google Scholar
• Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM, Molrine DC. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998; 22:735-41; PMID:9827969; http://dx.doi.org/10.1038/sj.bmt.1701424
   PubMed Web of Science ®Google Scholar
• Small TN, Zelenetz AD, Noy A, Rice RD, Trippett TM, Abrey L, Portlock CS, McCullagh EJ, Vanak JM, Mulligan AM, et al. Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2009; 15:1538-42; PMID:19896077; http://dx.doi.org/10.1016/j.bbmt.2009.07.018
   PubMed Web of Science ®Google Scholar
• Shetty AK, Winter MA. Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation. Ochsner J 2012; 12:228-43; PMID:23049460
   PubMedGoogle Scholar
• Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44:625-34; PMID:17278051; http://dx.doi.org/10.1086/511641
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58: e44-100; PMID:24311479; http://dx.doi.org/10.1093/cid/cit684
   PubMed Web of Science ®Google Scholar
• Kussmaul SC, Horn BN, Dvorak CC, Abramovitz L, Cowan MJ, Weintrub PS. Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant 2010; 45:1602-6; PMID:20190839; http://dx.doi.org/10.1038/bmt.2010.31
   PubMed Web of Science ®Google Scholar
• Danzinger-Isakov L, Kumar D; AST Infectious Diseases Community of Practice Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009; 9 Suppl. 4: S258-62; PMID:20070687; http://dx.doi.org/10.1111/j.1600-6143.2009.02917.x
   PubMedGoogle Scholar
• Ladd JM, Karkazis K, Magnus D. Parental refusal of vaccination and transplantation listing decisions: a nationwide survey. Pediatr Transplant 2013; 17:244-50; PMID:23347536; http://dx.doi.org/10.1111/petr.12046
   PubMed Web of Science ®Google Scholar
• Abuali MM, Arnon R, Posada R. An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant 2011; 15:770-7; PMID:22111996; http://dx.doi.org/10.1111/j.1399-3046.2011.01593.x
   PubMed Web of Science ®Google Scholar
• Davies K, Woo P. Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology 2002;41:937-41; PMID:12154212; http://dx.doi.org/10.1093/rheumatology/41.8.937
   PubMed Web of Science ®Google Scholar
• Minden K, Niewerth M, Borte M, Singedonk W, Haas JP. Immunization in children and adolescents with rheumatic diseases. Z Rheumatol 2007; 66:111-2; PMID:17364157; http://dx.doi.org/10.1007/s00393-007-0150-z
   PubMed Web of Science ®Google Scholar
• Dell' Era L, Esposito S, Corona F, Principi N. Vaccination of children and adolescents with rheumatic diseases. Rheumatology (Oxford) 2011; 50:1358-65; PMID:21482543; http://dx.doi.org/10.1093/rheumatology/ker102
   PubMed Web of Science ®Google Scholar
• Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 2011; 70:1704-12; PMID:21813547; http://dx.doi.org/10.1136/ard.2011.150193
   PubMed Web of Science ®Google Scholar
• Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients. Clin Exp Immunol 2014; 178:40-7; PMID:24889761; http://dx.doi.org/10.1111/cei.12390
   PubMed Web of Science ®Google Scholar
• Medical Advisory Committee of the Immune Deficiency Foundation, Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM, Bonilla FA, Conley ME, Cunningham-Rundles C, et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 2014; 133:961-6; PMID:24582311; http://dx.doi.org/10.1016/j.jaci.2013.11.043
   PubMed Web of Science ®Google Scholar